Novelgenix Theraps Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NOVELGENIX THERAPS, and what generic and branded alternatives to NOVELGENIX THERAPS drugs are available?
NOVELGENIX THERAPS has one approved drug.
Summary for Novelgenix Theraps
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Novelgenix Theraps
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novelgenix Theraps | NAPROXEN SODIUM | naproxen sodium | TABLET;ORAL | 207612-001 | Nov 16, 2018 | OTC | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
